Lyell Immunopharma Growth Metrics (2020-2026) | LYEL

Growth Metrics Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
0.08M0.16M-0.13M-1.10M0.23M-239.49M0.30M-8.41M-23.10M219.80M-39.88M-193.53M-12.12M7.09M-135.03M128.50M-18.25M-13.03M-59.56M-47.27M
EBITDA Margin Growth (3y) (Quarter)
-22.78M-19.52M-39.71M-203.03M-34.99M-12.59M-174.61M-73.43M-53.47M213.86M-234.47M-112.29M
EBITDA Margin Growth (5y) (Quarter)
-53.16M-25.46M-234.30M-121.79M
EBITDA Margin (QoQ) (Quarter)
-0.01M0.06M-0.12M-1.02M1.31M-239.65M239.66M-9.73M-13.38M3.25M-20.02M-163.38M168.02M22.46M-162.14M100.16M21.27M27.68M-208.67M112.45M
EBIT Margin Growth (1y) (Quarter)
0.09M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M
EBIT Margin Growth (3y) (Quarter)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M
EBIT Margin Growth (5y) (Quarter)
-58.60M-24.49M-212.57M-221.08M
EBIT Margin (QoQ) (Quarter)
-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.56M
EBT Margin Growth (1y) (Quarter)
0.09M0.16M955.00-1.01M0.23M-213.78M0.16M-7.70M-22.45M192.98M-40.32M-153.59M-12.28M7.87M-138.06M86.08M-20.09M-9.56M-29.89M-133.90M
EBT Margin Growth (3y) (Quarter)
-22.14M-20.64M-40.16M-162.29M-34.50M-12.92M-178.22M-75.20M-54.82M191.30M-208.28M-201.40M
EBT Margin Growth (5y) (Quarter)
-54.51M-22.32M-208.11M-210.11M
EBT Margin (QoQ) (Quarter)
-0.01M0.06M0.01M-1.07M1.22M-213.94M213.95M-8.93M-13.53M1.49M-19.35M-122.19M127.78M21.64M-165.29M101.95M21.61M32.17M-185.62M-2.06M
Enterprise Value Growth (1y) (Quarter)
-235.24%-360.46%-0.36%-151.22%20.49%-4.72%-4.12%0.19%9.12%11.22%14.67%14.11%17.56%23.44%32.17%42.77%43.64%27.45%33.28%15.66%
Enterprise Value Growth (3y) (Quarter)
-87.78%-34.30%-62.37%3.75%-29.14%15.86%10.71%15.53%21.13%24.98%20.99%27.18%25.44%
Enterprise Value Growth (5y) (Quarter)
-30.83%-2.39%-18.92%16.60%-0.78%
Enterprise Value (QoQ) (Quarter)
-237.41%24.94%0.67%0.14%-6.78%1.13%1.23%4.28%2.78%3.41%5.08%3.65%6.68%10.30%15.89%18.72%8.10%-15.48%22.65%-2.75%
FCF Margin Growth (1y) (Quarter)
0.44M-0.27M-0.65M0.21M-133.03M0.33M-6.30M-14.35M117.92M-31.27M-132.98M-15.19M4.74M-11.42M61.73M-13.84M-8.77M-11.56M-114.58M
FCF Margin Growth (3y) (Quarter)
-14.67M-31.22M-139.94M-29.34M-10.37M-42.37M-77.55M-43.38M113.89M-54.25M-185.82M
FCF Margin Growth (5y) (Quarter)
-18.70M-54.20M-192.78M
FCF Margin (QoQ) (Quarter)
-0.01M0.27M-0.38M-0.54M0.85M-132.96M132.98M-7.17M-7.20M-0.69M-16.22M-108.87M110.60M19.23M-32.37M-35.72M35.02M24.30M-35.17M-138.74M
Net Margin Growth (1y) (Quarter)
0.09M0.16M955.00-1.01M0.23M-213.78M0.16M-7.70M-22.45M192.98M-40.32M-153.59M-12.28M7.87M-138.06M86.08M-20.09M-9.56M-29.89M-133.90M
Net Margin Growth (3y) (Quarter)
-22.14M-20.64M-40.16M-162.29M-34.50M-12.92M-178.22M-75.20M-54.82M191.30M-208.28M-201.40M
Net Margin Growth (5y) (Quarter)
-54.51M-22.32M-208.11M-210.11M
Net Margin (QoQ) (Quarter)
-0.01M0.06M0.01M-1.07M1.22M-213.94M213.95M-8.93M-13.53M1.49M-19.35M-122.19M127.78M21.64M-165.29M101.95M21.61M32.17M-185.62M-2.06M
Operating Margin Growth (1y) (Quarter)
0.09M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M
Operating Margin Growth (3y) (Quarter)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M
Operating Margin Growth (5y) (Quarter)
-58.60M-24.49M-212.57M-221.08M
Operating Margin (QoQ) (Quarter)
-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.56M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.000.00M0.00M
Return on Assets Growth (3y) (Quarter)
0.00M0.00M-1.00-1.00-1.000.00M-1.00
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter)
-528.00-108.0092.00-514.00-275.00-0.00M-0.00M-961.00-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M293.00
Return on Capital Employed Growth (3y) (Quarter)
-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Return on Capital Employed (QoQ) (Quarter)
-134.00-229.00121.00-286.00286.00-29.00-485.00-47.00-754.00-133.00-28.00-92.00-0.00M-0.00M-0.00M208.000.00M-11.00
Return on Equity Growth (1y) (Quarter)
-1.00-1.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.00-1.000.00M0.00M
Return on Equity Growth (3y) (Quarter)
-1.00-1.000.00M0.00M-1.00-1.00-1.00-1.00-1.00-1.00
Return on Equity Growth (5y) (Quarter)
-2.00-2.00
Return on Equity (QoQ) (Quarter)
-1.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Sales Growth (1y) (Quarter)
9.0016.000.00M-101.0023.00-0.02M16.00-770.00-0.00M0.02M-0.00M-0.02M-0.00M787.00-0.01M0.01M-0.00M-956.00-0.00M-0.01M
Return on Sales Growth (3y) (Quarter)
-0.00M-0.00M-0.00M-0.02M-0.00M-0.00M-0.02M-0.01M-0.01M0.02M-0.02M-0.02M
Return on Sales Growth (5y) (Quarter)
-0.01M-0.00M-0.02M-0.02M
Return on Sales (QoQ) (Quarter)
-1.006.001.00-107.00122.00-0.02M0.02M-893.00-0.00M149.00-0.00M-0.01M0.01M0.00M-0.02M0.01M0.00M0.00M-0.02M-206.00